...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Rumors starting again
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Dutchfella,

 

If the ZEN3694 is working so well in the current trials the question is not when Zenith E will be purchased but when the right deal for both parties gets agreed upon,  Alot of moving parts takes a very long time to figure out, so the truth to those rumours may have be something there just the timeline may get extended to figure it out,  

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply